The Trouble With KRAS - Cancer Commons
Immune modulatory effects of oncogenic KRAS in cancer | Nature Communications
Role of oncogenic KRAS in the prognosis, diagnosis and treatment of colorectal cancer | Molecular Cancer | Full Text
Can KRAS Positive Colorectal and Lung Cancer Finally be Targeted? - CancerConnect
Integrated multi-omics characterization of KRAS mutant colorectal cancer
KRAS mutation: from undruggable to druggable in cancer | Signal Transduction and Targeted Therapy
Gene mutation profiling in Chinese colorectal cancer patients and its association with clinicopathological characteristics and prognosis - Ye - 2020 - Cancer Medicine - Wiley Online Library
Microsatellite Instability and KRAS Mutation in Stage IV Colorectal Cancer: Prevalence, Geographic Discrepancies, and Outcomes From the National Cancer Database in: Journal of the National Comprehensive Cancer Network Volume 19 Issue 3 (2021)
:max_bytes(150000):strip_icc()/kras-g12c-mutation-in-nsclc-4843957-v3-456bf340786c481b857d044b6a8cb307-b4828f2507074811b94472745e488299.png "KRAS Positive Lung Cancer: Testing and Management")
KRAS Positive Lung Cancer: Testing and Management
Cancers | Free Full-Text | Targeting Oncogenic KRAS in Non-Small-Cell Lung Cancer
,0.jpg "Progress towards individualized treatment of colorectal cancer UAB Barcelona")
Progress towards individualized treatment of colorectal cancer UAB Barcelona
Frontiers | Prognostic and therapeutic impact of the KRAS G12C mutation in colorectal cancer
KRAS and extended RAS molecular profiling in metastatic colorectal cancer | Colorectal Cancer
BRAF Mutation in Colorectal Cancer | IntechOpen
IJMS | Free Full-Text | Gene Therapy Targeting p53 and KRAS for Colorectal Cancer Treatment: A Myth or the Way Forward?
Molecular profile of KRAS G12C-mutant colorectal and non-small-cell lung cancer | BMC Cancer | Full Text
KRAS Mutation in Colon Cancer: A Marker of Resistance to EGFR-I Therapy | Annals of Surgical Oncology
Targeting KRAS mutant cancers: from druggable therapy to drug resistance | Molecular Cancer | Full Text
Frontiers | Targeting KRAS: The Elephant in the Room of Epithelial Cancers
Clinical characteristics and prognostic value of the KRAS mutation in Chinese colorectal cancer patients - Ye Yuan, Yingting Liu, Ye Wu, Junling Zhang, Chunti Shen, Feng Zhang, Changping Wu, Wenwei Hu, 2021
Frontiers | Targeting KRAS Mutant in Non-Small Cell Lung Cancer: Novel Insights Into Therapeutic Strategies
Frontiers | New Horizons in KRAS-Mutant Lung Cancer: Dawn After Darkness
KRas mutations spectrum in 670 colorectal cancers | Download Table
Tumor microenvironment-adjusted prognostic implications of the KRAS mutation subtype in patients with stage III colorectal cancer treated with adjuvant FOLFOX | Scientific Reports
Targeting the untargetable KRAS in cancer therapy - ScienceDirect
